Skip to main content
Premium Trial:

Request an Annual Quote

MDxHealth's Q1 Revenues Plunge 47 Percent

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MDxHealth today reported today a 47 percent drop in revenues year over year for the first quarter.

The Belgian molecular diagnostics firm said that revenues totaled €335,000 ($477,000) for the three months ended March 31, compared to €634,000 a year ago.

In a statement, the company attributed the decline in revenues to its shift from basic research to molecular diagnostics development, which resulted in a drop in grant revenues. During 2010, MDxHealth discontinued early-stage R&D projects that were not in line with its new strategy to develop clinical diagnostics and partner on companion diagnostic projects with pharmaceutical firms, the company said.

Its net loss for the quarter shrank 17 percent to €2 million from €2.4 million a year ago.

Jan Groen, CEO of MDxHealth, cited recent progress on the company's companion diagnostic development programs, which included a deal with Pfizer to develop a test to predict response to PARP inhibitors, as well as an investment round that raised €8.2 million. The funds will be used to set up a CLIA laboratory and a marketing infrastructure in the US, he said.

MDxHealth ended the quarter with €9.1 million.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.